SE
Septerna Inc
SEPN · NASDAQ
$38.69 +0.68% (+$0.26)
1M -4.52%
Market Cap $1.78B
P/E Ratio -
Div. Yield -
ROE 6.31%
Piotroski F-Score Weak
3/9Valuation
53 /100
Fair P/B 4.60x
P/FCF 16.94x
P/S 18.01x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
50 /100
Moderate Net margin 24.51%
Op. margin 44.04%
FCF margin 106.29%
Quality
2 /100
Poor ROE 6.31%
ROA 4.28%
Asset turnover 0.17x
Debt
100 /100
Low Current ratio 4.99x
Debt/Equity 0.06x
Net debt/EBITDA N/A
Stability
1 /100
Unstable EPS volatility 14,515.69%
Profitable years 0
Beta 2.29x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SEPN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey T. Finer
Employees
123
Headquarters
South San Francisco
Upcoming events
09 NOV
Earnings
Upcoming earnings report